![]() L-arginine [2S-[2alpha,5alpha,6beta(S*)]]-6-[amino(p-hydroxyphenyl)acetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate structure
|
Common Name | L-arginine [2S-[2alpha,5alpha,6beta(S*)]]-6-[amino(p-hydroxyphenyl)acetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate | ||
---|---|---|---|---|
CAS Number | 59261-05-1 | Molecular Weight | 539.605 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C22H33N7O7S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of L-arginine [2S-[2alpha,5alpha,6beta(S*)]]-6-[amino(p-hydroxyphenyl)acetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylateAmoxicillin (Amoxycillin) arginine is an antibiotic with good oral absorption and broad spectrum antimicrobial activity. Amoxicillin arginine inhibits the biosynthesis of polypeptides in the cell wall, thereby inhibiting cell growth[1][2][3]. |
Name | N5-(Diaminomethylene)-L-ornithine-(5S,6S)-6-{[amino(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (1:1) |
---|---|
Synonym | More Synonyms |
Description | Amoxicillin (Amoxycillin) arginine is an antibiotic with good oral absorption and broad spectrum antimicrobial activity. Amoxicillin arginine inhibits the biosynthesis of polypeptides in the cell wall, thereby inhibiting cell growth[1][2][3]. |
---|---|
Related Catalog | |
In Vitro | Amoxicillin (Amoxycillin) arginine (1-100 µM; 24 hours; L. acidophilus) decreases living cells and increases degree of cell wall rupture in a dose-dependent manner[1]. |
In Vivo | Amoxicillin (Amoxycillin) arginine (7 mg/kg; i.h.; female ICR/Swiss mice) inhibits strain numbers and improves the survival rate of rats in 1 mg/L or less[2]. Amoxicillin (Amoxycillin) arginine (1.6-9.5 mg/kg; p.o.; daily, for 7 or 14 days; swiss albino mice) has against infection with chlamydia trachomatis in mice[3]. Animal Model: Female ICR/Swiss mice[2] Dosage: 7 mg/kg Administration: Subcutaneous injection; every 8 h, for 24 hours Result: Inhibited bacterial numbers in a dose-dependent manner. Animal Model: Female ICR/Swiss mice[2] Dosage: 7 mg/kg Administration: Subcutaneous injection; every 8 h, for 4 days Result: Survived all animals that were infected with organisms for which MICs were 1 mg/L or less, and with the two strains for which MICs were 2 mg/L, 20 to 40% mortality. Animal Model: Swiss albino mice[3] Dosage: 1.6 and 9.5 mg/kg Administration: Oral administration; daily, for 7 or 14 days Result: Improved the activity of Chlamydia trachomatis infection in mice. |
References |
Molecular Formula | C22H33N7O7S |
---|---|
Molecular Weight | 539.605 |
Exact Mass | 539.216187 |
EINECS 261-680-4 |
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-, (5S,6S)-, compd. with L-ornithine, N5-(diaminomethylene)- (1:1) |
N5-(Diaminomethylene)-L-ornithine - (5S,6S)-6-{[amino(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (1:1) |